Company

Magnolia Medical Technologies, Inc.

Magnolia Medical Technologies makes the FDA-cleared Steripath device to reduce blood culture contamination in sepsis testing.

About

Its Steripath Initial Specimen Diversion Device is sold direct to hospitals and healthcare systems, and the Steripath Micro is offered for pediatric patients. Founded in 2006 and headquartered in Seattle, US, the company has raised USD 46.00 mn in total, including USD 10.00 mn in venture debt from Horizon Technology Finance in October 2022. CEO and founder Greg Bullington has guided the company since its inception.

5Funding rounds

7Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in